Jump to content
Sign in to follow this  
MComes RPH

Abbvie is Conducting a Parkinson's Disease Research Trial

Recommended Posts

Hi everyone,

I was just emailed by AbbVie Pharmaceuticals concerning a Parkinson's Research Study they are conducting.

AbbVie Clinical Pharmacology Research Unit (ACPRU) is currently enrolling people ages 45 to 85 for research studies for people who have been diagnosed with Parkinson's Disease.

There is no cost to participate and qualified participants may be eligible to receive compensation  of up to $1,500 for study participation.

Study staff will determine eligibility based on study criteria.

To learn more about the study and to see if you qualify, call 1-800-827-2778 or visit abbviephase1.com.

For more information, call:

AbbVie Pharmaceuticals


To find more specific information on this study, visit AbbViePhase1.com


***I, Mark Comes, have no ties to AbbVie Pharmaceutical Company with respect to financial relationships, stock entitlements, support for this information, money for this post. This information was sent to me because I am a pharmacist and have signed up to be notified of new medications, research studies, and FDA and DEA information about medications.

  • Like 1

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this